5-161330900-G-T
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_001371727.1(GABRB2):c.1060C>A(p.Arg354Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00000137 in 1,461,884 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R354H) has been classified as Benign.
Frequency
Consequence
NM_001371727.1 missense
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy 92Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Illumina, G2P
 - undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| GABRB2 | NM_001371727.1  | c.1060C>A | p.Arg354Ser | missense_variant | Exon 8 of 10 | ENST00000393959.6 | NP_001358656.1 | |
| GABRB2 | NM_021911.3  | c.1060C>A | p.Arg354Ser | missense_variant | Exon 9 of 11 | NP_068711.1 | ||
| GABRB2 | NM_000813.3  | c.1060C>A | p.Arg354Ser | missense_variant | Exon 9 of 10 | NP_000804.1 | 
Ensembl
Frequencies
GnomAD3 genomes  Cov.: 32 
GnomAD2 exomes  AF:  0.0000120  AC: 3AN: 249376 AF XY:  0.00   show subpopulations 
GnomAD4 exome  AF:  0.00000137  AC: 2AN: 1461884Hom.:  0  Cov.: 30 AF XY:  0.00  AC XY: 0AN XY: 727240 show subpopulations 
Age Distribution
GnomAD4 genome  Cov.: 32 
ClinVar
Submissions by phenotype
GABRB2-related disorder    Uncertain:1 
The GABRB2 c.1060C>A variant is predicted to result in the amino acid substitution p.Arg354Ser. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0087% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/5-160757907-G-T). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Intellectual disability    Uncertain:1 
This sequence change replaces arginine, which is basic and polar, with serine, which is neutral and polar, at codon 354 of the GABRB2 protein (p.Arg354Ser). This variant is present in population databases (no rsID available, gnomAD 0.009%). This variant has not been reported in the literature in individuals affected with GABRB2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1347808). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt GABRB2 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at